About
Lalo Flores is a Venture Partner at Scion Life Sciences and CEO of Flux Therapeutics, a Scion portfolio company. He has over 30 years of experience in the biopharmaceutical industry, beginning at Tularik (later acquired by Amgen) and holding senior R&D leadership roles at Merck and Johnson & Johnson. He co-founded Novira Therapeutics (acquired by Johnson & Johnson in 2015) and was founding CEO of Century Therapeutics, which he took public in 2021. He holds a doctorate in Biochemistry and Molecular Biology from Rutgers University and completed post-doctoral work at the Salk Institute.
Invests in
Biotech
Experience
- Stealth StartupChief Executive Officercurrent2023 — presentCambridge, Massachusetts, United States
- Century TherapeuticsChief Executive Officer2018 — 2023Greater Philadelphia Area
- Johnson & JohnsonEntrepreneur in Residence2018Spring House, PA
- Johnson & JohnsonVice President of R&D2015 — 2018Spring House, PA
- Novira TherapeuticsCo-founder, President and Chief Scientific Officer2009 — 2015Doylestown, PA
- MerckSenior Director2004 — 2008
- MerckDirector Antiviral Research1999 — 2004
- TularikScientist1992 — 1999
- The Salk InstitutePost Doctoral Fellow1991 — 1992
Skills & more
Therapeutic Areas11HCV4Lifesciences5Immunology6Endocrinology14Drug Discovery28Target Identification6Clinical Research10Drug Development12Osteoporosis5Biotechnology20
Languages Spanish
From Lalo's professional profile.
Colleagues at Scion Life Sciences
Aaron Kantoff
Managing Partner at Scion Life Sciences
Andreas Loew
Partner at Scion Life Sciences
Dave Katona
Head of Business Development & Investor Relations at Scion Life Sciences
Elliot Warner
Associate at Scion Life Sciences
Huw Nash
Venture Partner at Scion Life Sciences
Jeffrey Edelman
Partner at Scion Life Sciences
Megan Blewett
Principal at Scion Life Sciences
Romesh Subramanian
Venture Partner at Scion Life Sciences
Frequently asked questions
- Who is Lalo Flores?
- Lalo Flores is a Venture Partner at Scion Life Sciences and CEO of Flux Therapeutics, a Scion portfolio company. He has over 30 years of experience in the biopharmaceutical industry, beginning at Tularik (later acquired by Amgen) and holding senior R&D leadership roles at Merck and Johnson & Johnson. He co-founded Novira Therapeutics (acquired by Johnson & Johnson in 2015) and was founding CEO of Century Therapeutics, which he took public in 2021. He holds a doctorate in Biochemistry and Molecular Biology from Rutgers University and completed post-doctoral work at the Salk Institute.
- Where does Lalo Flores work?
- Lalo Flores is Venture Partner at Scion Life Sciences.
- What does Lalo Flores invest in?
- Lalo Flores invests in Biotech.
- Where did Lalo Flores go to school?
- Lalo Flores studied at Rutgers University (PhD, Biochemistry); Pontificia Universidad Católica de Valparaíso (BS, Biology).
Founder mafias
Rutgers University mafia29
Also came through, then founded or led a company.
Ryan BednarBSFounded RankScience +1Harsh YadavMaster of ScienceFounded Ryse +1Anshu AgarwalMaster of Science - MSFounded NimbellaTino WakedBAFounded TAPTAPKevin BittermanBAFounded Editas MedicineDave RosenbergB.A.Founded MuleSoft
_edited_edited.jpg)
+ 22 more
Johnson & Johnson mafia25
Also came through, then founded or led a company.
Serge MesserlianPresident, OncologyFounded Creyon +1Kim RodriguezDirector of SalesFounded BrainCheck +1Sid ViswanathanGlobal Operations Leadership DevelopmentFounded Alchemy Health +1Peter EmighFormulationsFounded Savoy LifeSebastian RualesCategory Management ManagerFounded BiaArthur SuckowPostdocFounded DTx Pharma
+ 18 more
Scion Life Sciences mafia6
Also came through, then founded or led a company.
Pontificia Universidad Católica de Valparaíso mafia2
Also came through, then founded or led a company.
Same school
Also attended Rutgers University120
Jigar RaythathaInvestor at Third Rock VenturesRobin LiInvestor at GGV CapitalDominique LittleGovernment Affairs Lead at ParadigmGanesh PersadVice President & Chief Information Officer at Flare Capital PartnersMark FieldsInvestor at Alsop Louie PartnersBasil AlomaryPrincipal, Head of Research & Growth Strategy at Stripes
+ 114 more
Also attended Pontificia Universidad Católica de Valparaíso5
Shared employers
Also worked at Stealth Startup351
Andrew ChenGeneral Partner at Andreessen HorowitzGabriel PereyraCo-founder & President of HarveyErica VanInvestment Director at Intel CapitalHemamAdvisor at Clear VenturesHamish GarnettAssociate at Manta Ray VenturesFranz KoflerInvestor at Next Frontier Capital
+ 345 more
Also worked at Johnson & Johnson151
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture PartnersBrad H. ValeFounding General Partner at Treo Ventures, Llc
+ 145 more
Also worked at Novira Therapeutics3
Also worked at Merck106
Anika GuptaInvestor at GV (Google Ventures)Sam BlackmanEntrepreneur in Residence at GV (Google Ventures)Catherine Pearce, DHSc, MBAAdvisor at CincyTechDavid MollerInvestor at Third Rock VenturesAlan EzekowitzInvestor at Third Rock VenturesAndrea van ElsasInvestor at Third Rock Ventures
+ 100 more